Xenon Pharmaceuticals (XENE) Other Gross PP&E Adjustments (2016 - 2025)
Xenon Pharmaceuticals (XENE) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with $792000.0 as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments fell 72.97% to $792000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $792000.0, a 72.97% decrease, with the full-year FY2025 number at $792000.0, down 72.97% from a year prior.
- Other Gross PP&E Adjustments was $792000.0 for Q4 2025 at Xenon Pharmaceuticals, up from -$9.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.9 million in Q4 2024 to a low of -$10.9 million in Q1 2023.
- A 5-year average of -$6.8 million and a median of -$8.3 million in 2022 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: tumbled 596.96% in 2021, then soared 439.91% in 2024.
- Xenon Pharmaceuticals' Other Gross PP&E Adjustments stood at -$7.1 million in 2021, then fell by 8.35% to -$7.7 million in 2022, then skyrocketed by 88.8% to -$862000.0 in 2023, then skyrocketed by 439.91% to $2.9 million in 2024, then tumbled by 72.97% to $792000.0 in 2025.
- Per Business Quant, the three most recent readings for XENE's Other Gross PP&E Adjustments are $792000.0 (Q4 2025), -$9.5 million (Q3 2025), and -$8.0 million (Q2 2025).